Disease progression in recently diagnosed patients with inherited marrow failure syndromes: A Canadian Inherited Marrow Failure Registry (CIMFR) report

Pediatric Blood and Cancer

Volumn 47, Issue 7, 2006, Pages 918-925

  Steele, J M ^a,b   Sung, L ^a   Klaassen, R ^a   Fernandez, C V ^a   Yanofsky, R ^a   Wu, J ^a   Odame, I ^a   Silva, M ^a   Champagne, J ^a   Ali, K ^a   Brossard, J ^a   Samson, Y ^a   Abish, S ^a   Le, D ^a   Jardine, L ^a   Hand, J P ^a   Lipton, J H ^a   Charpentier, K ^a   Stephens, D ^a   Freedman, M ^a   Dror, Y ^a,b,c   more..

^a Canadian Inherited Marrow Failure Registry   (Canada)

^b Division of Haematology/Oncology   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Canadian inherited marrow failure registry; Diagnosis; Inherited; Marrow failure; Natural history; Pediatric

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLACKFAN DIAMOND ANEMIA; BLOOD TRANSFUSION; BONE MARROW DEPRESSION; CANADA; CHILD; CHROMOSOME DISORDER; CYTOPENIA; DISEASE COURSE; DYSKERATOSIS CONGENITA; FANCONI ANEMIA; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; KAPLAN MEIER METHOD; KOSTMANN NEUTROPENIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MYELODYSPLASIA; NEUTROPENIA; NEWBORN; OUTCOMES RESEARCH; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; SHWACHMAN SYNDROME; SURVIVAL;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; BONE MARROW DISEASES; BONE MARROW EXAMINATION; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; REGISTRIES; SYNDROME;

EID: 33750435568     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20876     Document Type: Article

References (34)

1. Alter BP. Inherited bone marrow failure syndromes: introduction. In: Young N, Alter BP, editors. Aplastic anemia: Acquired and Inherited. 1st edition. Philadelphia: WB Saunders; 1994. pp 271-274.
2. Gorman Hughes DW. Aplastic anemia in childhood-constitutional aplastic anemia and related cytopenias. Med J Aust 1974;1:519-526.
3. Rogers PCJ, Desai F, Karabus CD. et al. Presentation and outcome of 25 cases of Fanconi's anemia. Amer J Pediatr Hematol Oncol 1989;11:141-145.
4. Bonilla MA, Dale D, Zeidler C. et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 1994;88:723-730.
5. Ginzberg H, Shin J, Ellis L. et al. Shwachman syndrome: Phenotypic manifestations of sibling sets and isolated cases in a large patient cohort. J Pediatr 1999;135:81-88.
6. Knight S, Vulliamy T, Copplestone A. et al. Dyskeratosis congenita registry: Identification of new features of DC. Br J Haematol 1998;103:990-996.
7. Freedman MH, Estrov Z. Congenital amegakaryocytic thrombocytopenia: An intrinsic hematopoietic stem cell defect. Am J Pediatr Hematol Oncol 1990;2:225-230.
8. Butturini A, Gale PG, Verlander PC. et al. Hematologic abnormalities in Fanconi anemia: An international Fanconi anemia registry study. Blood 1994;84:1650-1655.
9. Woods WG, Roloff JS, Lukens JN, et al. The occurrence of leukemia in patients with the Shwachman syndrome. J Pediatr 1981;99:425-428.
10. Smith O, Hann IM, Chessells JM. et al. Haematologic abnormalities in Shwachman-Diamond syndrome. Br J Haematol 1996;94:279-284.
11. Freedman MH, Bonilla MA, Fier C. et al. Myelodysplasia and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood 2000;96:429-436.
12. Kutler DI, Singh B, Satagopan J. et al. A 20-year perspective on the international Fanconi anemia registry (IFAR). Blood 2003;101:1249-1256.
13. Lipton JM, Federman N, Khabbase Y. et al. Osteogenic sarcoma associated with Diamond-Blackfan anemia: A report from the Diamond-Blackfan Registry. J Pediatr Hematol Oncol 2001;23:39-44.
14. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer 2003;97:425-440.
15. Windass B, Vowels MR, O'Gorman Hughes D, et al. Aplastic anemia in childhood: Prognosis and approach to therapy. Med J Aust 1987;146:15-19.
16. Alter BP, Potter NU, Li FP. Classification and aetiology of the aplastic anemias. Clin Haematol 1978;7:431-465.
17. Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Ginsburg D, Look T, editors. Hematology of Infancy and Childhood, 6th edition Philadelphia, PA: WB Saunders; 2003. pp 280-365.
18. Altman PL, Katz D. Blood and other bodily fluids. In: Federation of American societies for experimental biology. Washington, DC: Committee on biological handbooks; 1961.
19. Matoth Y, Zaizov R, Varsano I. Postnatal changes in some red cell parameters. Acta Paediatr Scand 1971;60:317-323.
20. Dipchand A, Ellis G, Petric M. Poon A Laboratory reference values. In: Dipchand A, editor. The HSC handbook of pediatrics. 9th edition Toronto, Canada: Mosby; 1997. pp 507-555.
21. Bennett JM, Catovsky D, Daniel MT. et al. Proposals for the classification of the myelodysplastic syndromes. Br J Hematol 1982;51:189-199.
22. Hasle H, Niemeyer CM, Chessels JM. et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003;17:277-282.
23. O'Gorman Hughes DW. The varied pattern of aplastic anemia in childhood. Aust Paediatric Journal 1966;2:228-236.
24. Szklo M, Sensenbrenner L, Markowitz J. et al. Incidence of aplastic anemia in metropolitan Baltimore: A population-based study. Blood 1985;66:115-119.
25. Linet MS, McCaffrey LD, Morgan WF. et al. Incidence of aplastic anemia in a three county area in South Carolina. Cancer Res 1986;46:426-429.
26. Mary JY, Baumelou E, Guiguet M. et al. Epidemiology of aplastic anemia in France: A prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood 1990;75:1646-1653.
27. Clausen N, Kreuger A, Salmi T. et al. Severe aplastic anemia in the Nordic countries: A population based study of incidence, presentation, course, and outcome. Arch Dis Child 1996;74:319-322.
28. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 2003;101:822-826.
29. Willig TN, Niemeyer CM, Leblanc T. et al. Identification of new prognostic factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. Pediatr Res 1999;553-561.
30. Kardos G, Baumann I, Passmore J, et al. Refractory anemia in childhood: A retrospective analysis of 67 patients with particular reference to monosomy 7. Blood 2003;102:1997-2003.
31. Heerema NA, Nachman JB, Sather HN, et al. Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: A report from the Children's Cancer Group. Leukemia 2004;18:939-947.
32. Alter BP, Caruso JP, Drachtman RA. et al. Fanconi anemia: Myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet 2000;117:125-131.
33. Dror Y, Durie P, Ginzberg H. et al. Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: A prospective 5-year follow-up study. Exp Hematol 2002;30:659-699.
34. Vlachos A, Klein GW, Lipton JM. The Diamond-Blackfan anemia registry: Tool for investigating the epidemiology and biology of Diamond-Blackfan anemia. J Pediatr Hematol Oncol 2001;23:377-382.